1
|
Harte G, Keane J, Ryan D, Collins R, Garcia C, Howlin R, Ryan S, Connolly A, Leitch E, Moynan W, Healy S, Keenan M. 321 UNMET NEEDS AFTER STROKE. Age Ageing 2022. [DOI: 10.1093/ageing/afac218.282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Unmet needs, such as lack of access to rehabilitation, support and information, are experienced by a high proportion of stroke survivors after discharge from acute and rehabilitation services. The UK guidelines on stroke (2016) recommend that all patients should be offered a structured health and social care review at 6 months post-stroke. However, no such clinics exist to date in Ireland. We aimed to explore the extent of unmet needs in the catchment area of a large teaching hospital.
Methods
A random selection of patients 6-months post-stroke were contacted by telephone and unmet needs were assessed using a validated tool, Post-Stroke Checklist. Following analysis of data, the need for a pilot clinic was identified. A separate random selection of patients discharged from acute services 6 months previously were invited to attend a review clinic. Patients were assessed using an adapted version of the Greater Manchester Stroke Assessment Tool. Assessments were conducted jointly by a physiotherapist and a speech and language therapist, and appropriate onward referrals were made.
Results
Telephone clinic: 51 patients completed the checklist. The most prevalent symptoms reported were fatigue (75%), reduced participation in hobbies and activities, decline in cognition (61%) and mobility problems (59%). Review clinic: 21 patients attended. The most prevalent symptoms reported were reduced memory/concentration (71%), low mood (71%), unintentional weight loss/gain (62%), and reduced mobility (43%). Onward referrals were made for in 16/21 (76%) cases; physiotherapy (n=12), occupational therapy (n=7), speech and language therapy (n=7), clinical nutrition (n=5), social work (n=7), psychology (n=5).
Conclusion
Data from this exploratory study supports previous research indicating a high number of stroke survivors with unmet needs. This highlights the importance of establishing post-acute stroke review clinics and pathways in the Irish setting.
Collapse
Affiliation(s)
- G Harte
- Tallaght University Hospital , Dublin, Ireland
| | - J Keane
- Tallaght University Hospital , Dublin, Ireland
| | - D Ryan
- Tallaght University Hospital , Dublin, Ireland
| | - R Collins
- Tallaght University Hospital , Dublin, Ireland
| | - C Garcia
- Tallaght University Hospital , Dublin, Ireland
| | - R Howlin
- Tallaght University Hospital , Dublin, Ireland
| | - S Ryan
- Tallaght University Hospital , Dublin, Ireland
| | - A Connolly
- Tallaght University Hospital , Dublin, Ireland
| | - E Leitch
- Tallaght University Hospital , Dublin, Ireland
| | - W Moynan
- Tallaght University Hospital , Dublin, Ireland
| | - S Healy
- Tallaght University Hospital , Dublin, Ireland
| | - M Keenan
- Tallaght University Hospital , Dublin, Ireland
| |
Collapse
|
2
|
Nair D, Martinek MR, Colley J, Sundaram S, Hariharan R, Morales G, Sommer P, Healy S, Siddiqui U, Williams C, Sarver A, Lo M. Paroxysmal atrial fibrillation ablation with a novel flexible tip radiofrequency catheter incorporating contact force sensing: acute results of the TactiFlex AF IDE trial. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.584] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Catheter ablation is an established therapy for paroxysmal atrial fibrillation (PAF). The TactiFlex™ Ablation Catheter, Sensor-Enabled™ (TactiFlex SE) is a next-generation radiofrequency ablation catheter incorporating highly accurate fiber optics-based contact force sensing technology with a flexible, laser-cut tip.
Purpose
To demonstrate that ablation with TactiFlex SE is safe and effective for the treatment of drug refractory, symptomatic PAF.
Methods
The TactiFlex AF IDE is a prospective, non-randomized, multi-center clinical study which enrolled 355 subjects worldwide. Enrollment in the main study began on June 26, 2020 and completed on June 18, 2021. Subjects underwent de novo Pulmonary Vein Isolation (PVI) and, if indicated, a Cavotricuspid Isthmus ablation (CTI line) for CTI-dependent atrial flutter.
Results
Subjects were divided into two as treated subgroups: High Standard Power (HSP, n=189), defined as subjects with 100% of left atrial lesions ablated at ≥40 W, and Low Standard Power (LSP, n=119), defined as subjects with at least one left atrial lesion ablated at <40W. First pass success, defined as isolation of all pulmonary veins (PVs) confirmed after a minimum 20 min waiting period was achieved in 93.5% (175/186) and 84.5% (98/116) of HSP and LSP subjects, respectively (p=0.0104). Significant decreases in the HSP versus LSP procedures were also seen in total procedure time (112.0 min [89.0, 139.5] and 149.0 [115.0, 182.0], respectively [p<0.001]), total RF time for PV ablation (14.0 min [11.0, 19.0] and 29.0 [19.0, 41.0], respectively [p<0.0001]), total fluoroscopy time (4.0 min [0.0, 11.0] and 8.0 [3.0, 17.0], respectively [p<0.0001]) and irrigation fluid volume (378.0 mL [310.0, 466.0] and 636.0 [476.0, 829.0], respectively [p<0.0001]) (values given as Median [Q1, Q3]), see Figure 1. Both HSP and LSP subjects had a low rate of repeat procedures (1.6% [3/182] and 4.3% [5/115], respectively [p=0.2684]) and primary safety endpoint events (4.8% [9/189] and 4.2% [5/119], respectively [p=0.8182]) through 90 days post-index procedure.
Conclusion
The acute data on the TactiFlex SE catheter demonstrates safe and effective treatment of PAF using either a HSP or LSP ablation strategy. Ablation procedures performed using a HSP strategy were shorter and required less irrigation fluid and fluoroscopy. It is anticipated these results will be reflected in the 12-month safety and effectiveness primary endpoints.
Funding Acknowledgement
Type of funding sources: Private company. Main funding source(s): Abbott
Collapse
Affiliation(s)
- D Nair
- St. Bernards Medical Center , Jonesboro , United States of America
| | - M R Martinek
- A. o. Krankenhaus her Elisabethinen Linz , Linz , Austria
| | - J Colley
- Jackson Heart Clinic , Jackson , United States of America
| | - S Sundaram
- South Denver Cardiology Associates PC , Littleton , United States of America
| | - R Hariharan
- Memorial Hermann Hospital , Houston , United States of America
| | - G Morales
- Affinity Cardiovascular Specialists, LLC , Birmingham , United States of America
| | - P Sommer
- Heart and Diabetes Center NRW , Bad Oeynhausen , Germany
| | - S Healy
- Monash Medical Centre , Melbourne , Australia
| | - U Siddiqui
- Advent Health Orlando , Orlando , United States of America
| | - C Williams
- Abbott , Saint Paul , United States of America
| | - A Sarver
- Abbott , Saint Paul , United States of America
| | - M Lo
- Arkansas Heart Hospital , Little Rock , United States of America
| |
Collapse
|
3
|
Nair D, Martinek M, Colley J, Sundaram S, Sharma S, Morales G, Sommer P, Healy S, Siddiqui U, Williams C, Sarver A, Lo M. Acute results of a novel flexible tip radiofrequency catheter incorporating contact force sensing. Europace 2022. [DOI: 10.1093/europace/euac053.077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Private company. Main funding source(s): Abbott
Background
Catheter ablation is an established therapy for paroxysmal atrial fibrillation (PAF). The TactiFlex Ablation Catheter, Sensor-Enabled (TactiFlex SE) is a next-generation radiofrequency ablation catheter incorporating highly accurate fiber optics-based contact force sensing technology with a flexible, laser-cut tip. This is the first report of results from the TactiFlex IDE clinical study.
Purpose
To demonstrate that ablation with TactiFlex SE is safe and effective for the treatment of drug refractory, symptomatic PAF.
Methods
The TactiFlex IDE (NCT04356040) is a prospective, non-randomized, multi-center clinical study which enrolled 305 subjects worldwide in the main study. Enrollment in the main study began on June 26, 2020 and completed on June 8, 2021. Subjects underwent de novo Pulmonary Vein Isolation (PVI) and, if indicated, a Cavotricuspid Isthmus ablation (CTI line) for CTI-dependent atrial flutter.
Results
Acute procedural success was achieved in 98.6% (274/278) of the main study cohort who underwent an ablation procedure using the TactiFlex SE. First pass success, defined as isolation of all pulmonary veins (PVs) confirmed after a minimum 20 min waiting period was achieved in 89.6% (249/278) of subjects. This was a significant improvement versus the TactiSense IDE trial (TactiCath Ablation Catheter, Sensor-Enabled). Significant decreases were also seen in total procedure time (123 min [101.0, 163.5]), total PV ablation time (55.5 min [35.0, 81.0]), total fluoroscopy time (6.0 min [0.0, 13.0]) and irrigation fluid volume (450.0 mL [346.0, 636.0]) (values given as Median [Q1, Q3]), see FIGURE. All subjects have completed at least 90 days of follow-up. Only 2.6% (7/271) of subjects required a repeat procedure during the 90-day blanking period. The primary safety and effectiveness endpoints will be evaluated at 12-months. At 90 days, 4.3% (12/281) subjects had experienced a primary safety endpoint event.
Conclusions
The acute data from the TactiFlex IDE clinical study demonstrate safety and effectiveness of the TactiFlex SE catheter in the treatment of PAF. Ablation procedures performed using the next-generation TactiFlex SE catheter were shorter and had improved acute clinical effectiveness outcomes versus the TactiSense IDE. It is anticipated these results will also be reflected in the 12-month safety and effectiveness endpoints.
Collapse
Affiliation(s)
- D Nair
- St. Bernards Medical Center, Jonesboro, United States of America
| | - M Martinek
- A. o. Krankenhaus her Elisabethinen Linz, Linz, Austria
| | - J Colley
- Jackson Heart Clinic, Jackson, United States of America
| | - S Sundaram
- South Denver Cardiology Associates PC, Denver, United States of America
| | - S Sharma
- Memorial Hermann Hospital, Houston, United States of America
| | - G Morales
- Affinity Cardiovascular Specialists, LLC, Birmingham, United States of America
| | - P Sommer
- Heart and Diabetes Center NRW, Bad Oeynhausen, Germany
| | - S Healy
- Monash Medical Center, Clayton, Australia
| | - U Siddiqui
- Advent Health Orlando, Orlando, United States of America
| | - C Williams
- Abbott, Saint Paul, United States of America
| | - A Sarver
- Abbott, Saint Paul, United States of America
| | - M Lo
- Arkansas Heart Hospital, Little Rock, United States of America
| |
Collapse
|
4
|
Healy S, Jessup P. Pulmonary nodular lymphoid hyperplasia presenting as multifocal lung opacities. Pathology 2021. [DOI: 10.1016/j.pathol.2021.05.071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
5
|
Dahlgren J, Healy S, MacDonald M, Geldhof J, Palmiere K, Haegele JA. Physical activity and screen time among youth with autism: A longitudinal analysis from 9 to 18 years. Autism 2021; 25:1090-1099. [PMID: 33406885 DOI: 10.1177/1362361320981314] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
LAY ABSTRACT To date, studies using cross-sectional methodologies make up a majority of the literature surrounding children with autism spectrum disorders and participation in physical activity and screen time. Longitudinal studies are needed to examine how physical activity and screen time behaviors co-develop for children with and without an autism spectrum disorder. To address this research gap, this study compared how physical activity and screen time levels changed over time (from 9 to 18 years of age) between youth with autism spectrum disorder and youth with neurotypical development. Data on the levels of moderate-to-vigorous physical activity, light physical activity, television-, and video game-based screen time, collected as a part of the "Growing up in Ireland" study, were compared between youth with autism spectrum disorder and a propensity-matched sample of youth with neurotypical development (n = 88 per group; 176 in total). Robust regression analyses indicated that children with autism spectrum disorder became less active over time compared to children with neurotypical development and that video game screen time also differed significantly between the groups when children were 9 years old. These findings elucidate important disparities present between these groups of children during pivotal developmental times.
Collapse
|
6
|
Chierchia G, Pavlovic N, Velagic V, Hermida J, Healy S, Arena G, Badenco N, Meyer C, Chen J, Iacopino S, Anselme F, Kuniss M. Quality of life measured in first-line therapy during the Cryo-FIRST study: a comparison between cryoballoon catheter ablation versus antiarrhythmic drug therapy. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0436] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
By consensus statements, catheter ablation is a recommended treatment for patients with symptomatic drug-refractory paroxysmal atrial fibrillation (AF), as patients try to alleviate the burdensome AF symptoms that reduce the Quality of Life (QoL). Yet, first-line treatment of symptomatic patients via catheter ablation prior to initiation of antiarrhythmic drugs (AADs) is only a reasonable alternative (Class IIa). Clearly, more clinical data is necessary that compares catheter ablation to AAD therapy in treatment naïve patients.
Purpose
The Cryo-FIRST trial was designed to compare AAD treatment against pulmonary vein isolation (PVI) while using a cryoballoon catheter (Arctic Front Advance; Medtronic, Inc.). This current data analysis examines the QoL endpoints when comparing AADs to cryoballoon ablation in patients with symptomatic treatment naïve paroxysmal AF.
Methods
This randomized multicenter trial enrolled 220 patients from 18 sites in 9 countries (Europe, Australia, and Latin America) in a prospective open-blinded endpoint study design. Patients had not been administered a class I or III AAD for longer than 48 hours for inclusion into the study. Subjects were randomized (1:1) into a cohort that was administered AAD therapy or a cohort that received PVI via cryoablation. The prespecified QoL endpoint at 12 months was measured using the Atrial Fibrillation Effect on Quality of Life (AFEQT) scores, and QoL recordings were taken at baseline, 1, 3, 6, 9, and 12 months following the index treatment.
Results
Of the 218 patients randomized (age 52±13 years, 68% male) 86% completed the 12-month follow-up. Crossovers occurred in 9% of subjects (N=20), including: 1 subject in the cryoablation arm and 19 subjects in the AAD arm. At 12 months, 86.5% of the patients in the cryoablation arm and 70.4% of the patients in the AAD arm where without symptoms (EHRA score 1). The mean AFEQT summary score was more favorable in the catheter ablation group compared to the drug therapy group at 12 months (88.9 vs. 78.1 points, respectively). The adjusted difference was 9.9 points (95% CI: 5.5–14.2; P<0.0001).
Conclusions
Cryoballoon ablation resulted in a significant improvement in QoL at 12 months compared to AAD therapy in treatment naïve patients with first-line symptomatic paroxysmal AF.
Funding Acknowledgement
Type of funding source: Private company. Main funding source(s): Medtronic International Trading Sàrl
Collapse
Affiliation(s)
- G.B Chierchia
- Vrije Universiteit Brussel, Postgraduate Course in Clinical ElectroPhysiology and Pacing, Heart Rhythm Management Center, Brussel, Belgium
| | - N Pavlovic
- Sestre Milosrdnice University Hospital Centre, Cardiology, Zagreb, Croatia
| | - V Velagic
- University Hospital Centre Zagreb, Cardiovascular Medicine, Zagreb, Croatia
| | - J.S Hermida
- Centre Hospitalier Universitaire d'Amiens-Picardie, Service de Cardiologie Rythmologie et Stimulation Cardiaque, Amiens, France
| | - S Healy
- Monash Health, MonashHeart, Clayton, Australia
| | - G Arena
- Ospedale Apuane, Cardiology, Massa Carrara, Italy
| | - N Badenco
- AP-HP Sorbonne Université, Hopital Pitié-Salpétrière, Cardiologie, Paris, France
| | - C Meyer
- University Heart Center, Department of Cardiology-Electrophysiology, Hamburg, Germany
| | - J Chen
- Haukeland University Hospital, Department of Heart Disease, Bergen, Norway
| | - S Iacopino
- Villa Maria Cecilia, Aritmologia, Cotignola, Italy
| | - F Anselme
- CHU de Rouen, Cardiologie, Rouen, France
| | - M Kuniss
- Kerckhoff Heart Center, Cardiology, Bad Nauheim, Germany
| |
Collapse
|
7
|
Lee J, Adam D, Bittinger L, Pick A, Healy S, Kotschet E. 310 Computed Tomography Pulmonary Venogram Characteristics of Patients Undergoing Hybrid Atrial Fibrillation Ablation. Heart Lung Circ 2020. [DOI: 10.1016/j.hlc.2020.09.317] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
8
|
Alasti M, Kotschet E, Adam D, Healy S, Bittinger L, Krafchek J, Alison J. Failure rate in Biotronik Linox/Sorin Vigila ICD leads. Heart Lung Circ 2019. [DOI: 10.1016/j.hlc.2019.06.186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
9
|
Kamhieh Y, Fox H, Healy S, Hallett E, Quine S, Owens D, Tomkinson A, Thomas C, Smith D, Ingrams D, Passant C, Pope L, Marnane C, Berry S. Total glossolaryngectomy cohort study (N = 25): Survival, function and quality of life. Clin Otolaryngol 2018; 43:1349-1353. [PMID: 29667326 DOI: 10.1111/coa.13121] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/07/2018] [Indexed: 11/28/2022]
Affiliation(s)
- Y Kamhieh
- Royal Glamorgan Hospital, Llantrisant, UK
| | - H Fox
- Royal Glamorgan Hospital, Llantrisant, UK
| | - S Healy
- Royal Gwent Hospital, Newport, UK
| | - E Hallett
- Royal Glamorgan Hospital, Llantrisant, UK
| | - S Quine
- University Hospital Wales, Cardiff, UK
| | - D Owens
- University Hospital Wales, Cardiff, UK
| | | | - C Thomas
- University Hospital Wales, Cardiff, UK
| | - D Smith
- Royal Glamorgan Hospital, Llantrisant, UK
| | | | | | - L Pope
- Morriston Hospital, Swansea, UK
| | | | - S Berry
- Royal Glamorgan Hospital, Llantrisant, UK
| | | |
Collapse
|
10
|
Cheshire C, Alison J, Healy S, Lockwood S, Kotschet E. Endocardial Left Ventricle Lead Implantation for Cardiac Resynchronisation Therapy. Heart Lung Circ 2017. [DOI: 10.1016/j.hlc.2017.06.314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
11
|
Kotschet E, Healy S, Hunter M. Andersen-Tawil Syndrome: Treatment of Bidirectional VT When Beta Blockers Fail to Suppress Arrhythmia. Heart Lung Circ 2017. [DOI: 10.1016/j.hlc.2017.06.261] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
12
|
Harvey M, Kotschet E, Healy S, Rudolph L, Alison J. Establishing a Nurse Led Multidisciplinary Atrial Fibrillation Clinic. Heart Lung Circ 2017. [DOI: 10.1016/j.hlc.2017.06.640] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
13
|
Cheshire C, Alison J, Lockwood S, Healy S, Kotschet E. Cardiac Contractility Modulator Insertion for Heart Failure: A Single Centre Australian Experience. Heart Lung Circ 2017. [DOI: 10.1016/j.hlc.2017.06.305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
14
|
Mutha V, Rangasamy K, Healy S, Kotschet E, Adam D, Bittinger L, Krafchek J, Alison J. Initial Australian Experience with Sub-Cutaneous Implantable Cardiac Defibrillators (S-ICD). Heart Lung Circ 2016. [DOI: 10.1016/j.hlc.2016.06.350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
15
|
Healy S, Willis MD, Pickersgill TP, Page M, Robertson NP. THYROTOXICOSIS SECONDARY TO ALEMTUZUMAB TREATMENT FOR MULTIPLE SCLEROSIS PRESENTING AS PULMONARY HYPERTENSION. J Neurol Psychiatry 2015. [DOI: 10.1136/jnnp-2015-312379.109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Alemtuzumab has been approved for use in the treatment of relapsing multiple sclerosis. Despite its proven clinical efficacy acquired autoimmune disease remains a significant risk. In particular thyroid disease is common and robust surveillance mechanisms are required to identify disease at an early stage. We present the case of a 31-year-old female patient who presented with signs consistent with pulmonary hypertension as the presenting feature of thyrotoxicosis. 12-months after the first alemtuzumab treatment course the patient presented to clinic with a 2-week history of exertional dyspnoea, palpitations and headaches. On examination, she had a new pansystolic murmur loudest in the pulmonary area and bilateral pitting oedema to the knees. An echocardiogram demonstrated elevated right ventricular pressure (40 mm Hg) and tricuspid regurgitation consistent with pulmonary hypertension. A CT pulmonary angiogram did not demonstrate evidence of a pulmonary embolus. Thyroid function tests revealed profound thyrotoxicosis (free T4 37.3 pmol/l and TSH <0.02 mU/l), which was thought to be the likely cause. Carbimazole was started but discontinued due to a rash with euthyroidism eventually achieved with radio-iodine. Her symptoms have subsequently resolved. This case highlights the need for neurologists using Alemtuzumab to be vigilant of the varied and sometimes acute presentations of thyroid dysfunction; and the growing repertoire of induced autoimmunity.
Collapse
|
16
|
Healy S, Willis MD, Robertson NP. Prognosis in multiple sclerosis and the unveiling of pathogenic clues. J Neurol 2015; 262:2596-8. [PMID: 26514835 DOI: 10.1007/s00415-015-7938-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- S Healy
- Department of Neurology, Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff, UK
| | - M D Willis
- Department of Neurology, Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff, UK
| | - N P Robertson
- Department of Neurology, Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff, UK.
| |
Collapse
|
17
|
Mutha V, Robertson A, Youngs N, Adam D, Krafchek J, Bittinger L, Healy S, Alison J, Kotschet E. Arrhythmia detection via remote monitoring of cardiac devices: the MonashHeart experience. Heart Lung Circ 2015. [DOI: 10.1016/j.hlc.2015.06.297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
18
|
Robertson A, Mutha V, Versteege K, Adam D, Krafchek J, Healy S, Kotschet E, Alison J. Remote day one post implant monitoring of new devices: The MonashHeart experience. Heart Lung Circ 2015. [DOI: 10.1016/j.hlc.2015.06.320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
19
|
Tung M, Halim R, Nogic J, Pang B, Kotschet E, Adam D, Adams M, Bittinger L, Healy S, Cameron J, Alison J. Safety and efficacy of patient controlled sedation using propofol for cardiac rhythm management procedures. Heart Lung Circ 2015. [DOI: 10.1016/j.hlc.2015.04.145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
20
|
Kohler S, Asadov DA, Bründer A, Healy S, Khamraev AK, Sergeeva N, Tinnemann P. Ambulatory tuberculosis treatment in post-Semashko health care systems needs supportive financing mechanisms. Int J Tuberc Lung Dis 2014; 18:1390-5. [PMID: 25517802 DOI: 10.5588/ijtld.14.0190] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
The tuberculosis (TB) control strategy in the Republic of Karakalpakstan, Uzbekistan, is being changed to decentralised out-patient care for most TB patients by the Government of Uzbekistan, in collaboration with the international medical humanitarian organisation Médecins Sans Frontières. Ambulatory treatment of both drug-susceptible and drug-resistant TB from the first day of treatment has been recommended since 2011. Out-patient treatment of TB from the beginning of treatment was previously prohibited. However, the current Uzbek health financing system, which evolved from the Soviet Semashko model, offers incentives that work against the adoption of ambulatory TB treatment. Based on the 'Comprehensive TB Care for All' programme implemented in Karakalpakstan, we describe how existing policies for the allocation of health funds complicate the scale-up of ambulatory-based management of TB.
Collapse
Affiliation(s)
- S Kohler
- Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - D A Asadov
- Department of Health Management, Evidence-based Medicine Centre, Tashkent Institute of Postgraduate Medical Education, Tashkent
| | - A Bründer
- Médecins Sans Frontières, Nukus and Tashkent
| | - S Healy
- Médecins Sans Frontières, Nukus and Tashkent
| | - A K Khamraev
- Tashkent Paediatric Medical Institute, Nukus Branch, Nukus, Uzbekistan
| | - N Sergeeva
- Médecins Sans Frontières, Nukus and Tashkent
| | - P Tinnemann
- Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany
| |
Collapse
|
21
|
Chapman R, Somani B, Robertson A, Healy S, Kata S. Decreasing Cost of Flexible Ureterorenoscopy: Single-use Laser Fiber Cost Analysis. Urology 2014; 83:1003-5. [DOI: 10.1016/j.urology.2013.12.019] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2013] [Revised: 11/04/2013] [Accepted: 12/13/2013] [Indexed: 11/25/2022]
|
22
|
Healy S, Lang J, Te Water Naude J, Gibbon F, Leach P. Vagal nerve stimulation in children under 12 years old with medically intractable epilepsy. Childs Nerv Syst 2013; 29:2095-9. [PMID: 23681311 DOI: 10.1007/s00381-013-2143-3] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/22/2013] [Accepted: 04/30/2013] [Indexed: 11/26/2022]
Abstract
OBJECTIVE This study aims to assess the efficacy and safety of vagal nerve stimulation (VNS) in children less than 12 years old operated on at the University Hospital Wales. METHOD Retrospective review of patients undergoing VNS insertion, over a 3-year period, was undertaken. All children had a minimum follow-up period of 2 years. Sixteen patients were identified via the paediatric epilepsy surgery database. A case note review and telephone evaluation was conducted. Seizure frequency using the McHugh classification was the primary outcome measure, with anti-epileptic drug (AED) use as a secondary outcome measure. RESULTS There were 10 males and 6 females. The mean time with epilepsy prior to surgery was 5.7 years and the mean age at the time of surgery was 7.6 years. Overall, nine (56 %) children experienced a reduction in their seizure frequency of 50 % or more. Of these, four (25 %) had a reduction of more than 80 %. Seven children (44 %) had no reduction in their seizure frequency, although two of these patients reported benefit regarding seizure control and post-ictal recovery. The VNS system was removed in two patients due to infection and no benefit, respectively. Half of the cohort (50 %) reduced the number of anti-epileptic drugs post-surgery, and there was an overall mean reduction of AED of 0.5. CONCLUSION This study suggests that VNS is a safe and effective adjuvant therapy in children under 12 years old, with over half reporting significant benefit. Further studies are needed to enable preoperative selection of patients in order to maximise the potential benefit.
Collapse
Affiliation(s)
- S Healy
- College of Medicine, University Hospital of Wales, Cardiff, UK
| | | | | | | | | |
Collapse
|
23
|
Chee K, Munday F, Franzini C, Leather R, Sterns L, Novak P, Lane C, Healy S, Tang A. The Evolving Trends of Atrial Fibrillation Ablation From 2007 to 2012. Can J Cardiol 2013. [DOI: 10.1016/j.cjca.2013.07.303] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
24
|
Healy S, Dietrich S, Roth T, Nyang'wa BT, Ducros P. Public health advocacy for the Berlin Declaration on tuberculosis in the former Soviet Union: The view of Médecins Sans Frontières. Eur J Microbiol Immunol (Bp) 2012; 2:282-6. [PMID: 24265910 PMCID: PMC3832068 DOI: 10.1556/eujmi.2.2012.4.6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2012] [Accepted: 08/22/2012] [Indexed: 11/19/2022] Open
Abstract
To assist international efforts to address major gaps in the availability and accessibility of quality diagnosis and treatment for multi-drug resistant tuberculosis, Médecins Sans Frontières has adapted an approach combining three sets of interlinked strategies: direct provision of medical care, operational research, and public health advocacy. The activities undertaken are reviewed each in turn, with stress on the ways that they impact upon and consolidate each other. In spite of new opportunities, including technologies which significantly improve diagnosis and new, more patient-centred approaches, a much broader international mobilization is needed in order to confront MDR-TB. It is also questionable as to whether existing technologies are successful enough to provide a solid basis for expanded national programs.
Collapse
|
25
|
Affiliation(s)
- S Healy
- Sue Healy is at the Dept of Zoology, University of Oxford, Oxford, UK 0X1 3PS
| |
Collapse
|
26
|
Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Scott RJ, McGuffog L, Healy S, Sinilnikova OM, Rennert G, Lejbkowicz F, Flugelman A, Andrulis IL, Glendon G, Ozcelik H, Thomassen M, Paligo M, Aretini P, Kantala J, Aroer B, von Wachenfeldt A, Liljegren A, Loman N, Herbst K, Kristoffersson U, Rosenquist R, Karlsson P, Stenmark-Askmalm M, Melin B, Nathanson KL, Domchek SM, Byrski T, Huzarski T, Gronwald J, Menkiszak J, Cybulski C, Serrano P, Osorio A, Cajal TR, Tsitlaidou M, Benítez J, Gilbert M, Rookus M, Aalfs CM, Kluijt I, Boessenkool-Pape JL, Meijers-Heijboer HEJ, Oosterwijk JC, van Asperen CJ, Blok MJ, Nelen MR, van den Ouweland AMW, Seynaeve C, van der Luijt RB, Devilee P, Easton DF, Peock S, Frost D, Platte R, Ellis SD, Fineberg E, Evans DG, Lalloo F, Eeles R, Jacobs C, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Godwin A, Bove B, Stoppa-Lyonnet D, Caux-Moncoutier V, Belotti M, Tirapo C, Mazoyer S, Barjhoux L, Boutry-Kryza N, Pujol P, Coupier I, Peyrat JP, Vennin P, Muller D, Fricker JP, Venat-Bouvet L, Johannsson OT, Isaacs C, Schmutzler R, Wappenschmidt B, Meindl A, Arnold N, Varon-Mateeva R, Niederacher D, Sutter C, Deissler H, Preisler-Adams S, Simard J, Soucy P, Durocher F, Chenevix-Trench G, Beesley J, Chen X, Rebbeck T, Couch F, Wang X, Lindor N, Fredericksen Z, Pankratz VS, Peterlongo P, Bonanni B, Fortuzzi S, Peissel B, Szabo C, Mai PL, Loud JT, Lubinski J. Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer 2012; 106:2016-24. [PMID: 22669161 PMCID: PMC3388557 DOI: 10.1038/bjc.2012.160] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2011] [Revised: 03/18/2012] [Accepted: 03/25/2012] [Indexed: 01/28/2023] Open
Abstract
BACKGROUND The variable penetrance of breast cancer in BRCA1/2 mutation carriers suggests that other genetic or environmental factors modify breast cancer risk. Two genes of special interest are prohibitin (PHB) and methylene-tetrahydrofolate reductase (MTHFR), both of which are important either directly or indirectly in maintaining genomic integrity. METHODS To evaluate the potential role of genetic variants within PHB and MTHFR in breast and ovarian cancer risk, 4102 BRCA1 and 2093 BRCA2 mutation carriers, and 6211 BRCA1 and 2902 BRCA2 carriers from the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA) were genotyped for the PHB 1630 C>T (rs6917) polymorphism and the MTHFR 677 C>T (rs1801133) polymorphism, respectively. RESULTS There was no evidence of association between the PHB 1630 C>T and MTHFR 677 C>T polymorphisms with either disease for BRCA1 or BRCA2 mutation carriers when breast and ovarian cancer associations were evaluated separately. Analysis that evaluated associations for breast and ovarian cancer simultaneously showed some evidence that BRCA1 mutation carriers who had the rare homozygote genotype (TT) of the PHB 1630 C>T polymorphism were at increased risk of both breast and ovarian cancer (HR 1.50, 95%CI 1.10-2.04 and HR 2.16, 95%CI 1.24-3.76, respectively). However, there was no evidence of association under a multiplicative model for the effect of each minor allele. CONCLUSION The PHB 1630TT genotype may modify breast and ovarian cancer risks in BRCA1 mutation carriers. This association need to be evaluated in larger series of BRCA1 mutation carriers.
Collapse
Affiliation(s)
- A Jakubowska
- Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Healy S, Ling L, Adam D, Krafchek J, Kotschet E, Alison J, Cameron J, Meredith I. Day Case Electrophysiology Studies: A Five-Year Single Centre Experience. Heart Lung Circ 2012. [DOI: 10.1016/j.hlc.2012.05.298] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
28
|
Gamble S, Healy S, Ching S, Bui T, Reynolds M, Alison J. Device Related Infection in Day Case versus Overnight Stay Patients – A Prospective Single Centre Study. Heart Lung Circ 2011. [DOI: 10.1016/j.hlc.2011.05.228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
29
|
Murphy EF, Cotter PD, Healy S, Marques TM, O'Sullivan O, Fouhy F, Clarke SF, O'Toole PW, Quigley EM, Stanton C, Ross PR, O'Doherty RM, Shanahan F. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 2010; 59:1635-42. [PMID: 20926643 DOI: 10.1136/gut.2010.215665] [Citation(s) in RCA: 650] [Impact Index Per Article: 46.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/08/2022]
Abstract
BACKGROUND AND AIMS Increased efficiency of energy harvest, due to alterations in the gut microbiota (increased Firmicutes and decreased Bacteroidetes), has been implicated in obesity in mice and humans. However, a causal relationship is unproven and contributory variables include diet, genetics and age. Therefore, we explored the effect of a high-fat (HF) diet and genetically determined obesity (ob/ob) for changes in microbiota and energy harvesting capacity over time. METHODS Seven-week-old male ob/ob mice were fed a low-fat diet and wild-type mice were fed either a low-fat diet or a HF-diet for 8 weeks (n=8/group). They were assessed at 7, 11 and 15 weeks of age for: fat and lean body mass (by NMR); faecal and caecal short-chain fatty acids (SCFA, by gas chromatography); faecal energy content (by bomb calorimetry) and microbial composition (by metagenomic pyrosequencing). RESULTS A progressive increase in Firmicutes was confirmed in both HF-fed and ob/ob mice reaching statistical significance in the former, but this phylum was unchanged over time in the lean controls. Reductions in Bacteroidetes were also found in ob/ob mice. However, changes in the microbiota were dissociated from markers of energy harvest. Thus, although the faecal energy in the ob/ob mice was significantly decreased at 7 weeks, and caecal SCFA increased, these did not persist and faecal acetate diminished over time in both ob/ob and HF-fed mice, but not in lean controls. Furthermore, the proportion of the major phyla did not correlate with energy harvest markers. CONCLUSION The relationship between the microbial composition and energy harvesting capacity is more complex than previously considered. While compositional changes in the faecal microbiota were confirmed, this was primarily a feature of high-fat feeding rather than genetically induced obesity. In addition, changes in the proportions of the major phyla were unrelated to markers of energy harvest which changed over time. The possibility of microbial adaptation to diet and time should be considered in future studies.
Collapse
Affiliation(s)
- E F Murphy
- Alimentary Pharmabiotic Centre, University College Cork, Ireland
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Froese D, Healy S, McDonald M, Kochan G, Oppermann U, Niesen F, Gravel R. Thermolability of mutant MMACHC protein in the vitamin B12-responsive cblC disorder. Mol Genet Metab 2010; 100:29-36. [PMID: 20219402 PMCID: PMC2923755 DOI: 10.1016/j.ymgme.2010.02.005] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/21/2009] [Revised: 02/04/2010] [Accepted: 02/05/2010] [Indexed: 11/29/2022]
Abstract
Methylmalonic aciduria and homocystinuria, cblC type, is the most common inborn error of cellular vitamin B12 metabolism. We previously showed that the protein carrying the mutation responsible for late-onset cblC (MMACHC-R161Q), treatable with high dose OHCbl, is able to bind OHCbl with wild-type affinity, leaving undetermined the disease mechanism involved [Froese et al., Mechanism of responsiveness, Mol. Genet. Metab. (2009).]. To assess whether the mutation renders the protein unstable, we investigated the thermostability of the wild-type and mutant MMACHC proteins, either unbound or bound to different cobalamins (Cbl), using differential scanning fluorimetry. We found that MMACHC-wt and MMACHC-R161Q are both very thermolabile proteins in their apo forms, with melting temperatures (T(m)) of 39.3+/-1.0 and 37.1+/-0.7 degrees C, respectively; a difference confirmed by unfolding of MMACHC-R161Q but not MMACHC-wt by isothermal denaturation at 35 degrees C over 120 min. However, with the addition of OHCbl, MMACHC-wt becomes significantly stabilized (Delta T(m max)=8 degrees C, half-maximal effective ligand concentration, AC(50)=3 microM). We surveyed the effect of different cobalamins on the stabilization of the wild-type protein and found that AdoCbl was the most stabilizing, exerting a maximum increase in T(m) of approximately 16 degrees C, followed by MeCbl at approximately 13 degrees C, each evaluated at 50 microM cofactor. The other cobalamins stabilized in the order (CN)(2)Cbi>OHCbl>CNCbl. Interestingly, the AC(50)'s for AdoCbl, MeCbl, (CN)(2)Cbi and OHCbl were similar and ranged from 1-3 microM, which compares well with the K(d) of 6 microM for OHCbl [Froese et al., Mechanism of responsiveness, Mol. Genet. Metab. (2009).]. Unlike MMACHC-wt, the mutant protein MMACHC-R161Q is only moderately stabilized by OHCbl (Delta T(m max)=4 degrees C). The dose-response curve also shows a lower effectivity of OHCbl with respect to stabilization, with an AC(50) of 7 microM. MMACHC-R161Q showed the same order of stabilization as MMACHC-wt, but each cobalamin stabilized this mutant protein less than its wild-type counterpart. Additionally, MMACHC-R161Q had a higher AC(50) for each cobalamin form compared to MMACHC-wt. Finally, we show that MMACHC-R161Q is able to support the base-off transition for AdoCbl and CNCbl, indicating this mutant is not blocked in that respect. Taken together, our results suggest that protein stability, as well as propensity for ligand-induced stabilization, contributes to the disease mechanism in late-onset cblC disorder. Our results underscore the importance of cofactor stabilization of MMACHC and suggest that even small increases in the concentration of cobalamin complexed with MMACHC may have therapeutic benefit in children with the late-onset, vitamin responsive cblC disease.
Collapse
Affiliation(s)
- D.S. Froese
- Department of Biochemistry and Molecular Biology, University of Calgary, Alberta Children’s Hospital Research Institute for Child and Maternal Health, Calgary, Alta., Canada T2N 4N1
- Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom
| | - S. Healy
- Department of Biochemistry and Molecular Biology, University of Calgary, Alberta Children’s Hospital Research Institute for Child and Maternal Health, Calgary, Alta., Canada T2N 4N1
| | - M. McDonald
- Department of Biochemistry and Molecular Biology, University of Calgary, Alberta Children’s Hospital Research Institute for Child and Maternal Health, Calgary, Alta., Canada T2N 4N1
| | - G. Kochan
- Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom
| | - U. Oppermann
- Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom
- Nuffield Department of Orthopedic Surgery, Rheumatology and Musculoskeletal Sciences, Botnar Research Center, Biomedical Research Unit, University of Oxford, Oxford, United Kingdom
| | - F.H. Niesen
- Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom
| | - R.A. Gravel
- Department of Biochemistry and Molecular Biology, University of Calgary, Alberta Children’s Hospital Research Institute for Child and Maternal Health, Calgary, Alta., Canada T2N 4N1
- Corresponding author. Address: Room 250, Heritage Medical Research Building, University of Calgary, 3330 Hospital Drive NW, Calgary, Alta., Canada T2N 4N1.
| |
Collapse
|
31
|
Nasis A, Moir S, Seneviratne S, Healy S, Cameron J, Mottram P. Assessment of Global and Regional Left Ventricular Function and Volumes with 320-Slice MDCT: A Comparison with 2D-Echocardiography. Heart Lung Circ 2010. [DOI: 10.1016/j.hlc.2010.06.397] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
32
|
Painter JN, Willemsen G, Nyholt DR, Hoekstra C, Duffy D, Henders A, Wallace L, Healy S, Cannon-Albright LA, Skolnick M, Martin NG, Boomsma DI, Montgomery GW. 138. GENOME-WIDE LINKAGE SCAN FOR FAMILIAL DIZYGOTIC TWINNING. Reprod Fertil Dev 2010. [DOI: 10.1071/srb10abs138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
The tendency to conceive dizygotic (DZ) twins is a complex trait influenced by genetic and environmental factors. To search for new candidate loci for twinning we have conducted a genome-wide linkage scan in 525 families using microsatellite and single nucleotide polymorphism (SNP) marker panels. Non-parametric linkage analyses including 523 families containing a total of 1115 mothers of DZ twins (MODZT) from Australia and New Zealand (ANZ) and The Netherlands (NL) produced four linkage peaks above the threshold for suggestive linkage, including a highly suggestive peak at the extreme telomeric end of chromosome 6 with an exponential (exp)LOD score of 2.813 (P = 0.0002). Since the DZ twinning rate increases steeply with maternal age independent of genetic effects, we also investigated linkage including only families where at least one MODZT gave birth to her first set of twins before the age of 30. These analyses produced a maximum expLOD score of 2.718 (p = 0.0002), largely due to linkage signal from the ANZ cohort, however, ordered subset analyses indicated this result is most likely a chance finding in the combined dataset. Linkage analyses were also performed for two large DZ twinning families from the USA, one of which produced a peak on chromosome 2 in the region of two potential candidate genes. Sequencing of FSHR and FIGLA, along with INHBB in MODZTs from two large NL families with family-specific linkage peaks directly over this gene, revealed a potentially functional variant in the 5’ untranslated region of FSHR that segregated with the DZ twinning phenotype in the UT family. Work is continuing screening candidate genes. Our data provide further evidence for complex inheritance of familial DZ twinning.
Collapse
|
33
|
Froese DS, Zhang J, Healy S, Gravel RA. Mechanism of vitamin B12-responsiveness in cblC methylmalonic aciduria with homocystinuria. Mol Genet Metab 2009; 98:338-43. [PMID: 19700356 DOI: 10.1016/j.ymgme.2009.07.014] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/11/2009] [Revised: 07/22/2009] [Accepted: 07/22/2009] [Indexed: 11/28/2022]
Abstract
Patients with the cblC vitamin B(12) (cobalamin, cbl) disorder are defective in the intracellular synthesis of adenosylcobalamin and methylcobalamin and have combined homocystinuria and methylmalonic aciduria. While other vitamin B(12) disorders are treatable with high dose cyanocobalamin (CNCbl) or hydroxocobalamin (OHCbl), cblC patients respond well to OHCbl but not to CNCbl. Patient mutations were introduced into recombinant MMACHC (cblC) protein and the binding of CNCbl and OHCbl was examined. Three mutations were analyzed: G147D, associated with early onset, vitamin B(12) unresponsive disease; R161Q, associated with late onset disease that is highly responsive to OHCbl; and H122A, selected to test the hypothesis that H122 is central to a proposed vitamin B(12) binding motif on MMACHC. We report here that wild-type MMACHC binds both OHCbl and CNCbl with similar, tight affinity (K(d)=5.7 microM). We also report that MMACHC binds CNCbl in the base-off form, with the dimethylbenzimidazole (DMB) base of cobalamin displaced from coordination with the cobalt. In this form, wild-type MMACHC is able to reductively decyanate CNCbl to cob(II)alamin requiring only the presence of NADPH and FAD. We demonstrate that MMACHC with the G147D mutation is unable to bind either CNCbl or OHCbl, providing a straight forward explanation for the absence of response to either vitamin form. However, we show that MMACHC containing the R161Q mutation binds OHCbl with wild-type affinity, but is disturbed in binding CNCbl and has impaired decyanation. Finally, we show that H122A has reduced binding, but like R161Q, it binds OHCbl more tightly than CNCbl, suggesting that this histidine is not absolutely required for binding. These studies suggest that the ability of mutant MMACHC to respond to vitamin therapy depends on its ability to bind the vitamin with significant affinity, and for CNCbl, also on its ability to bind in the base-off form to facilitate reductive decyanation. These studies emphasize the continued use of OHCbl with cblC patients for maximum therapeutic effect.
Collapse
Affiliation(s)
- D S Froese
- Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alta., Canada.
| | | | | | | |
Collapse
|
34
|
Ko B, Hutchison A, Healy S, Nasis A, Zhang J, Cameron J, Meredith I, Malaiapan Y. A comparison of clinical outcomes in STEMI patients treated with primary angioplasty with and without post stent balloon dilatation. Heart Lung Circ 2009. [DOI: 10.1016/j.hlc.2009.05.494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
35
|
Adebayo GI, Williams J, Healy S. Aspirin esterase activity - Evidence for skewed distribution in healthy volunteers. Eur J Intern Med 2007; 18:299-303. [PMID: 17574104 DOI: 10.1016/j.ejim.2006.12.004] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/13/2006] [Revised: 06/26/2006] [Accepted: 12/14/2006] [Indexed: 11/30/2022]
Abstract
BACKGROUND Aspirin, with its analgesic, anti-inflammatory, antipyretic, and anti-platelet actions, is one of the most frequently used drugs. Although its use as prophylaxis against thromboembolism is well established, an optimal dose, conferring maximal anti-platelet action without increased risk of bleeding, remains elusive. METHOD We assessed the possible pharmacokinetic contribution to this problem in 107 healthy, non-medicated volunteers. Serum aspirin esterase activity was evaluated at 37 degrees C with 1 mM aspirin as substrate. On the basis of the report that most of aspirin esterase activity is accounted for by pseudocholinesterase, we additionally quantified the activity of this enzyme, with and without dibucaine as an inhibitor, using Ellman's reaction, in 41 of our volunteers. RESULTS Aspirin esterase activities in all of our volunteers (33.90 nmol/ml/min to 222.65 nmol/ml/min, median 103.45 nmol/ml/min) showed a continuous and skewed distribution with eight outliers. In the 41 subjects so studied, aspirin esterase activities correlated positively with both pseudocholinesterase activities (Spearman's rho=0.593, p<0.001) and dibucaine numbers (Spearman's rho=0.422, p<0.01). CONCLUSIONS Our results support previous observations that the rate of aspirin hydrolysis is not determined by aspirin esterase alone and that other factors are probably involved. Additionally, the skewed distribution of aspirin esterase activities makes a case for its possible contribution to the phenomenon of aspirin resistance.
Collapse
Affiliation(s)
- G I Adebayo
- Department of Medicine, Sligo General Hospital, The Mall, Sligo, Ireland
| | | | | |
Collapse
|
36
|
Kerckhoffs R, Bordachar P, Healy S, Omens J, McCulloch A. Myocardial mechanics during epicardial versus endocardial left ventricular pacing: simulations and experiments. J Biomech 2006. [DOI: 10.1016/s0021-9290(06)84130-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
37
|
Adebayo GI, Williams J, Healy S. Pseudocholinesterase polymorphism in an Irish population. Eur J Intern Med 2005; 16:492-5. [PMID: 16275543 DOI: 10.1016/j.ejim.2005.03.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/22/2004] [Revised: 03/17/2005] [Accepted: 03/18/2005] [Indexed: 10/25/2022]
Abstract
BACKGROUND Pseudocholinesterase polymorphism, as an example of pharmacogenetics with important clinical implications, has been widely studied and documented. However, data on a sample Irish population is lacking. We sought to provide this. METHOD In an assay involving Ellman's reaction, pseudocholinesterase activity, alone and with dibucaine or fluoride as an inhibitor, was quantified using propionylthiocholine iodide as substrate. RESULTS Pseudocholinesterase activities of 1.13-12.71 U/ml (mean +/- SD 6.74 +/- 2.04 U/ml) showed a normal distribution among our 116 healthy, non-medicated volunteers, aged 11-80 years (30.7 +/- 10.5 years) and weighing 46-114.6 kg (66.8 +/- 11.4 kg). However, dibucaine numbers from an inhibition study yielded a trimodal pattern consistent with the hypothesis of two allelic genes. Using an established nomenclature, 92 (79.3%) of our volunteers were homozygous for the usual form of the enzyme (E1uE1u). Of the 13 genotyped as E1uE1a, it is possible that 3 were misclassified and are probably E1kE1a. Only one volunteer was homozygous for the atypical form of the enzyme, with activity of 1.13 U/ml and dibucaine and fluoride number of 18.2 and 82.8, respectively. CONCLUSION The continuous variation in pseudocholinesterase activity and the trimodal pattern of dibucaine numbers are both in accord with observations in other population groups. Although dibucaine number yields a trimodal pattern, its use could lead to misclassification of some E1kE1a as E1uE1a.
Collapse
Affiliation(s)
- G I Adebayo
- Department of Medicine, Garavogue Centre, Level 3, Sligo General Hospital, The Mall, Sligo, Ireland
| | | | | |
Collapse
|
38
|
Rushe N, Ball M, Carroll WM, Healy S, McManus J, Cunningham D. Cytocompatibility of novel tin oxide thin films. J Mater Sci Mater Med 2005; 16:247-252. [PMID: 15744616 DOI: 10.1007/s10856-005-6686-z] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/26/2004] [Accepted: 07/19/2004] [Indexed: 05/24/2023]
Abstract
The capacity of tin oxide films to support cell growth was investigated. Three substrates were used for the test: glass coverslips, glass coverslips spin coated with tin oxide and commercially available 316 stainless steel. The wettabilities and surface roughness of the three surfaces were measured before seeding 3T3 fibroblasts onto the samples. The behaviour of the cells grown on the tin oxide was compared to the uncoated glass and the steel and results showed that the cell growth on tin oxide compared favourably with the other substrates. The surface wettability appeared to have the strongest effect on cell adhesion to tin oxide.
Collapse
Affiliation(s)
- N Rushe
- National Centre for Biomedical Engineering Science, National University of Ireland, Galway, Ireland.
| | | | | | | | | | | |
Collapse
|
39
|
Abstract
The use of tube feeding in some patients can be controversial, however, few studies have investigated dietitians' opinions on this subject. A cross-sectional survey of 345 members the Irish Nutrition and Dietetic Institute was conducted using a self-administered, anonymous, postal questionnaire. A 44% response rate was achieved. Mean number of years qualified was 9.3 (8.4). Eighty-one per cent of responders were involved in initiating tube feeding in stroke patients, and 8.5% in discontinuing tube feeding in a patient in a persistent vegetative state (PVS). Nine per cent felt that their input had no influence on the care plan of the patient with dementia and 67% felt that the information given to families (or other decision makers) concerning tube feeding was inadequate. The majority of respondents favoured tube feeding fictitious stroke and cancer patients, but less than half favoured tube feeding a fictitious patient in a PVS or a patient with dementia. When given similar scenarios involving themselves, fewer dietitians wanted to be tube fed.
Collapse
Affiliation(s)
- S Healy
- School of Biological Sciences, Dublin Institute of Technology, Kevin Street, Dublin 7, Republic of Ireland
| | | |
Collapse
|
40
|
Abstract
This paper utilises the notion of the risk society to argue that the ways in which technical practices, knowledge and rationality have become structured into governance are counter-productive and now instrumental to the proliferation of risk and destabilisation of governance. This problem is epitomised by how decisions have evolved to become a matter determined by 'facts' rather than by a determination of the community impact of outcomes and further compounded by the institutionally embedded blindness to wider social concerns that this entails. It is argued that what are required are processes integrating 'factual' technical and 'value-laden' societal concerns and avenues for this and their ramifications are elaborated and explored. Central to such developments will be a democratisation of technical practices and the institutions in which they are embedded. The broader political implications of these developments are examined and found to involve a radical extension of democracy involving an extensive reshaping of the topography of governance.
Collapse
Affiliation(s)
- S Healy
- School of Science and Technology Studies, University of New South Wales, NSW 2052, Sydney, Australia.
| |
Collapse
|
41
|
Cope JB, Yamashita J, Healy S, Dechow PC, Harper RP. Force level and strain patterns during bilateral mandibular osteodistraction. J Oral Maxillofac Surg 2000; 58:171-8; discussion 178-9. [PMID: 10670596 DOI: 10.1016/s0278-2391(00)90333-1] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
PURPOSE Recent reports have demonstrated that device orientation is important during mandibular distraction osteogenesis. The purpose of this study was to evaluate the force level and strain patterns on the mandible during bilateral osteodistraction with devices oriented either parallel to the body of the mandible or parallel to the sagittal axis of distraction. MATERIALS AND METHODS Five unembalmed human cadaver mandibles were placed in a specially designed apparatus for stabilization of the proximal segments during distraction. A force transducer was attached to the lateral aspect of the inferior ramus, and strain gauges were attached to the mandibular bone segments proximal and distal to the distraction device. Lateral force and bone strains were then measured at 5 and 10 mm of distraction. Osteodistraction proceeded first with the devices placed parallel to the mandibular body, then parallel to the axis of distraction. RESULTS Significantly greater lateral forces were seen when the devices were oriented parallel to the mandibular body. With this device orientation, increased tensile strains were seen at the labial symphysis and medial ramus, and increased compressive strains were found at the lingual symphysis and lateral ramus. However, when the devices were oriented parallel to the axis of distraction, the forces and strains were not detected. CONCLUSIONS The results suggest that device orientation has important biomechanical effects on lateral forces and strain patterns during mandibular osteodistraction.
Collapse
Affiliation(s)
- J B Cope
- TAMUS-Baylor College of Dentistry, Department of Orthodontics, Dallas, TX 75266-0677, USA.
| | | | | | | | | |
Collapse
|
42
|
Huntley R, Healy S, Freeman D, Lavender P, de Jager S, Greenwood J, Makker J, Walker E, Jackman M, Xie Q, Bannister AJ, Kouzarides T, Gutiérrez C, Doonan JH, Murray JA. The maize retinoblastoma protein homologue ZmRb-1 is regulated during leaf development and displays conserved interactions with G1/S regulators and plant cyclin D (CycD) proteins. Plant Mol Biol 1998; 37:155-169. [PMID: 9620273 DOI: 10.1023/a:1005902226256] [Citation(s) in RCA: 70] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
Recent discoveries of plant retinoblastoma (Rb) protein homologues and D-type cyclins suggest that control of the onset of cell division in plants may have stronger parallels with mammalian G1/S controls than with yeasts. In mammals, the Rb protein interacts specifically with D-type cyclins and regulates cell proliferation by binding and inhibiting E2F transcription factors. However, the developmental role of Rb in plants and its potential interaction with cell cycle regulators is unknown. We show that the maize Rb homologue ZmRb-1 is temporally and spatially regulated during maize leaf development. ZmRb-1 is highly expressed in differentiating cells, but almost undetectable in proliferating cells. In vitro, both ZmRb-1 and human Rb bind all classes of plant D-type cyclins with the involvement of a conserved N-terminal Leu-x-Cys-x-Glu (LxCxE) Rb-interaction motif. This binding is strongly reduced by mutation of the conserved Cys-470 of ZmRb-1. ZmRb-1 binds human and Drosophila E2F, and inhibits transcriptional activation of human E2F. We also show that ZmRb-1 is a good in vitro substrate for all human G1/S protein kinases. The functional conservation of proteins that control the G1/S transition in mammals and plants points to the existence of plant E2F homologues. We conclude that evolution of Rb and cyclin D proteins occurred after separation of the fungi from the higher eukaryotic lineage, but preceded the divergence of plant and animal kingdoms.
Collapse
Affiliation(s)
- R Huntley
- Institute of Biotechnology, University of Cambridge, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Abstract
The UL5, UL8, and UL52 genes of herpes simplex virus type 1 encode a multisubunit assembly that possesses primase, DNA helicase, and DNA-dependent nucleoside triphosphatase activities. A subassembly consisting of the UL5 and UL52 gene products retains these activities. The nucleoside triphosphatase activity of the UL5/UL52 subassembly is strongly stimulated by both homo- and heteropolymeric single-stranded DNA. Double-stranded DNA has little ability to stimulate the ATPase activity. The subassembly binds both double and single-stranded DNA. Nucleotides are not required for DNA-binding. The minimum length of single-stranded DNA that is bound and that stimulates enzymatic activity is about 12 nucleotides. The kinetic parameters of the ATPase activity of the subassembly are affected by the length of the oligonucleotide coeffector. The Km decreases as the coeffector length is increased up to a length of about 20 nucleotides and then remains independent of coeffector length. The first order rate constant for ATPase activity exhibits a quasihyperbolic dependence on the length of the DNA coeffector and is maximal for coeffectors of 20 nucleotides and longer.
Collapse
Affiliation(s)
- S Healy
- Department of Biochemistry, University of Arizona, Tucson, Arizona 85721-0088, USA
| | | | | |
Collapse
|
44
|
Zhang J, Warwick PJ, Wolfrum E, Key MH, Danson C, Demir A, Healy S, Kalantar DH, Kim NS, Lewis CL, Lin J, MacPhee AG, Neely D, Nilsen J, Pert GJ, Smith R, Tallents GJ, Wark JS. Saturated output of a Ge. Phys Rev A 1996; 54:R4653-R4656. [PMID: 9914140 DOI: 10.1103/physreva.54.r4653] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
|
45
|
Peat I, Healy S, Reid D, Ralston S. 95043686 Steroid induced osteoporosis: An opportunity for prevention? Maturitas 1995. [DOI: 10.1016/0378-5122(95)99340-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
46
|
Rizik DG, Healy S, Margulis A, Vandam D, Bakalyar D, Timmis G, Grines C, O'Neill WW, Schreiber TL. A new clinical classification for hospital prognosis of unstable angina pectoris. Am J Cardiol 1995; 75:993-7. [PMID: 7747701 DOI: 10.1016/s0002-9149(99)80710-3] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Unstable angina represents a heterogeneous spectrum of clinical entities between chronic stable angina and acute myocardial infarction. To facilitate prognostication of in-hospital outcome, we prospectively tested on a priori unstable angina classification scheme based on information available at the time of acute presentation. Prospective database enrollment at the time of emergency room presentation was performed and patients were classified into 1 of the following categories: class IA, acceleration of previous exertional angina without electrocardiographic (ECG) changes; class IB, acceleration of previous exertional angina with ECG changes; class II, new-onset exertional angina; class III, new-onset rest angina; class IV, protracted rest angina with ECG changes. The study consisted of 1,387 consecutive patients with unstable angina. Baseline demographics and aggregate in-hospital major cardiac event rates were recorded (myocardial infarction, refractory angina, and death). There was a significant increasing trend in cardiac events from class I to IV (p < 0.0001). Class IA patients had the lowest aggregate event rate at 2.7% (p = 0.0005). Paired chi-square tests of adjacent categories showed no differences in event rates for class IB and II (p = 0.3). A significantly higher rate of adverse events was seen for class III patients (20.1%, p < 0.0001). Class IV patients demonstrated the highest rate of in-hospital adverse events (42.8%, p < 0.0001). We conclude that this easily deduced, universally applicable categorization of unstable angina is highly prognostic of in-hospital adverse cardiac events and hence could have potential use for triage decisions regarding hospital admission and intensity of therapy.
Collapse
Affiliation(s)
- D G Rizik
- William Beaumont Hospital, Royal Oak, Michigan, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Abstract
OBJECTIVE To determine the frequency with which osteoporosis prophylaxis is given to corticosteroid treated hospital inpatients. METHODS All patients receiving systemic corticosteroids in a large teaching hospital over a three month period were identified through routine prescription monitoring by hospital ward pharmacists. Coprescription of antiosteoporotic therapy was recorded, along with other relevant details such as steroid dose, actual, or intended duration of therapy, and indication for therapy. RESULTS Corticosteroids were prescribed to 214 patients over the study period, giving an average rate of 2.5 new prescriptions each day. Indications included: chest disease (n = 84; 39.2%), cancer (n = 17; 7.9%), inflammatory bowel disease (n = 16; 7.5%), rheumatoid arthritis/connective tissue disease (n = 16; 7.5%), and renal diseases (n = 7; 3.3%). One hundred and twelve patients (52.3%) were receiving short term steroid therapy (less than four months); 66 (37%) were receiving medium/long term steroid therapy (four months or more). In 36 cases (16.8%) the duration of therapy was unknown. Only 12 of the 214 patients (5.6%) received any form of osteoporosis prophylaxis. The prevalence of prophylaxis was similarly low in postmenopausal women (six of 93; 6.4%) and in patients receiving high dose long term steroid therapy (two of 25; 8%). CONCLUSIONS Systemic corticosteroids are used frequently in hospital practice for a wide range of indications, but few patients receive co-prescription of prophylaxis against osteoporosis. This is true even in high risk groups such as postmenopausal women and those on high dose long term steroid therapy. Identification of individuals by the mechanism used in this study provides an opportunity by which all corticosteroid treated patients could be detected and offered osteoporosis prophylaxis before serious loss of bone density has occurred.
Collapse
Affiliation(s)
- I D Peat
- Department of Medicine and Therapeutics, University of Aberdeen, United Kingdom
| | | | | | | |
Collapse
|
48
|
Healy M, O’Moore R, Keane EM, Coakley D, Walsh JB, Tully M, Swanwick G, Coen R, Bruce I, O’Mahony D, Radic A, O’Kelly F, O’Doherty M, Lawlor BA, Lee H, Conway J, Keane E, Ng K, Murphy S, Khaw KT, May H, Compston JE, Taggart H, Crawford V, Twomey C, Delaney L, Crowley M, Hyland M, Hegarty V, Donovan MC, Pye M, Reardon M, Coleman P, Hyland CM, Scott T, Keane CT, Farragher B, O’Connor A, Quinn E, Mahony D, Rowan M, Buggy F, Freyne A, Wrigley M, Passmore AP, Crawford VLS, Beringer TRO, Gilmore DH, Hussain A, Grant D, Montgomery A, Hemeryck L, McCormack PME, Sheehan N, Guely A, Leonard L, Caulfield D, Nic Cártaigh M, Feely J, Mulkerrin E, Clark BA, Epstein FH, Keane N, McCabe E, Shepherd M, O’Donnell MJ, Cooper RA, Nurzaman M, Brooks RW, Sinha SK, Kane D, McKiernan M, Crowe J, Lennon J, Sheehan J, Rearden M, Hyland M, Tracey F, Lawson JT, Stout RW, Williams H, Naguib M, O’Keefe S, Lavan J, Madigan SM, McNulty H, Eaton-Evans J, Strain JJ, Stanwick G, Horgan F, Keating D, Crowe M, McNamara A, Leahy P, Healy S, Moraes D, Tyrell J, Crawford VLS, O’Keeffe S, Glasgow R, Tormey W, Finucane P, Nair BK, McCann C, Coen RF, O’Boyle CA, Joyce CRB, Hiltbrunner B, Clarke R, Cooney J. Irish Gerontological Society. Ir J Med Sci 1994. [DOI: 10.1007/bf02940568] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
49
|
Abstract
Female volunteers completed the Fawcett-Clark Pleasure Capacity Scale (FCPCS) and rated the pleasantness and desirability of a taste stimulus (cheese), before and during a depressive mood swing. Mood change was induced by reading negative self-referent statements, with additional 'booster' periods of mood induction to prolong the duration of the mood swing. The mood induction procedure (MIP) caused a decrease in contentment and alertness, as derived from a set of visual analogue mood scales, and also decreased hedonic capacity, as measured by responses to the taste stimulus and by the FCPCS. No changes on any measure were shown by a control group who read an equivalent set of positive self-referent statements. Prior to the MIP, there were no significant correlations between mood measures and hedonic measures, or between taste responses and the FCPCS. However, there were significant correlations between the size of the changes in these various measures following the depressive MIP. The results suggest that hedonic capacity is responsive to acute depressive mood swings.
Collapse
Affiliation(s)
- P Willner
- Dept. of Psychology, University of Wales, Swansea, UK
| | | |
Collapse
|
50
|
Healy S. Health care reform--another view. Todays OR Nurse 1994; 16:4. [PMID: 8066593] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
|